Almay Clear Complexion Concealer

Description

ALM CC CONCEALER ART is a cosmetic product effective as of March 5, 2021. It is presented in a media type of image/jpeg, with a referenced image titled "ALMAY CC CONCEALER CARD.jpg." The product is designed for use in cosmetic applications, specifically for concealing imperfections on the skin.

Uses and Indications

This drug is indicated for the treatment of acne. It helps to clear existing acne blemishes and prevent the formation of new acne lesions.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The affected area should be covered with a thin layer of the product one to three times daily, depending on the patient's needs and the physician's recommendations.

To minimize the risk of excessive drying of the skin, it is advisable to initiate treatment with one application per day. The frequency may be gradually increased to two or three times daily as tolerated. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day.

For new users, a sensitivity test is recommended. This involves applying the product sparingly to one or two small affected areas during the first three days of use. If no discomfort is experienced, the user may then proceed to follow the standard application instructions.

Contraindications

Use of this product is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a poison control center is advised.

Warnings and Precautions

Skin irritation and dryness may occur with the concurrent use of this product and other topical acne medications. To minimize the risk of irritation, it is advised to use only one topical acne medication at a time.

Contact with the eyes should be strictly avoided. In the event of accidental contact, it is imperative to flush the eyes thoroughly with water to mitigate potential harm.

This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or a poison control center should be contacted without delay.

No specific instructions for discontinuation of use and consultation with a healthcare provider were provided in the available information.

Side Effects

Patients using this medication may experience skin irritation and dryness, particularly if they concurrently use another topical acne medication. It is advised that only one topical acne medication be used at a time to minimize the risk of irritation.

Additionally, patients should avoid contact with the eyes. In the event of contact, it is recommended to flush the eyes thoroughly with water to alleviate any potential discomfort.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Almay Clear Complexion Concealer (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a poison control center is advised.

For application, it is recommended to start with one application daily to minimize the risk of excessive skin drying. If tolerated, the frequency may be gradually increased to two or three times daily, as directed by a healthcare professional. Should any bothersome dryness or peeling occur, the application frequency should be reduced to once a day or every other day.

For new users, a sensitivity test is advised. This involves applying the product sparingly to one or two small affected areas for the first three days. If no discomfort is experienced, the patient may proceed with the recommended application regimen.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Safety during pregnancy has not been established for this product. The use of salicylic acid is contraindicated in pregnancy due to potential risks to the fetus. Salicylic acid may pose risks during pregnancy; therefore, it is essential for pregnant patients to consult a healthcare provider before use.

Dosage adjustments may be necessary for pregnant individuals, and medical advice should be sought to determine appropriate use. Pregnant women should avoid using this product unless directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the substance involved, estimated dose, and time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should be instructed to seek medical help or contact a poison control center immediately. It is important for patients to understand the potential risks associated with improper use and the necessary steps to take in case of an emergency.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to protect the contents from light exposure, which can compromise the product's efficacy. Additionally, it is important to discard the product after opening to ensure safety and effectiveness.

Additional Clinical Information

The product is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily to minimize the risk of excessive skin drying, gradually increasing to two or three times daily as needed or directed by a clinician. If dryness or peeling becomes bothersome, patients are advised to reduce the frequency of application to once a day or every other day.

Clinicians should counsel patients to keep the product out of reach of children and to seek medical assistance or contact a poison control center immediately if the product is swallowed. Prior to application, patients should ensure that the skin is thoroughly cleaned. New users are encouraged to perform a sensitivity test by applying the product sparingly to one or two small affected areas for the first three days; if no discomfort occurs, they may proceed with the standard application regimen.

Drug Information (PDF)

This file contains official product information for Almay Clear Complexion Concealer, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)